SCHEMBL4995249

SCHEMBL4995249

COc1cccc(-c2ccc(C(N)=O)cc2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 3/20 0.67
PLG P00747 2/20 0.67
PLAT P00750 2/20 0.67
CHEK2 O96017 1/20 0.67
PARP1 P09874 2/20 0.67
MKNK1 Q9BUB5 1/20 0.63
MKNK2 Q9HBH9 1/20 0.63
PARP10 Q53GL7 2/20 0.59
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59
PARP2 Q9UGN5 1/20 0.59
PARP4 Q9UKK3 1/20 0.59
MAP4K4 O95819 1/20 0.59
HSD17B2 P37059 1/20 0.57
TRPV1 Q8NER1 1/20 0.55
MAOB P27338 2/20 0.54
HDAC4 P56524 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
RXRA P19793 1/20 0.53
RXRB P28702 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30958376 1.00 PLAU (0.67) PLAUPLGPLATCHEK2PARP1
SCHEMBL1690557 0.88 PARP1 (0.80) PLAUPLGPLATCHEK2PARP1
SCHEMBL30278441 0.85 RXRA (0.72) PLAUPLGPLATCA1CA2
SCHEMBL30837207 0.85 PLAU (0.58) PLAUPLGPLATHSD17B2TRPV1
SCHEMBL2998997 0.85 PLAU (0.58) PLAUPLGPLATHSD17B2TRPV1
SCHEMBL505652 0.85 RXRA (0.72) PLAUPLGPLATCA1CA2
SCHEMBL28188209 0.84 RXRA (0.71) PLAUPLGPLATCHEK2PARP1
SCHEMBL6716525 0.83 PLAU (0.60) PLAUPLGPLATCA1CA2
SCHEMBL6637315 0.83 PLAU (0.57) PLAUPLGPLATCHEK2HSD17B2
SCHEMBL3720494 0.83 PARP1 (0.67) PLAUPLGPLATPARP1PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8349836-B2 Phthalazine derivatives as inhibitors of protein kinase ARALDI GIAN-LUCA (US) 2013-01-08 US disclosed
EP-2131656-A2 PHTHALAZINE DERIVATIVES Forest Laboratories Holdings Limited (BM) 2009-12-16 EP disclosed
US-20080146547-A1 PHTHALAZINE DERIVATIVES FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-06-19 US disclosed
WO-2008061108-A2 PHTHALAZINE DERIVATIVES FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146547-A1 PHTHALAZINE DERIVATIVES CDK5, HIPK2, PACSIN2 PLAU 2997/4885PLG 3650/4885PLAT 4060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.